Cargando…
P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621491/ http://dx.doi.org/10.1097/01.HS9.0000890936.73031.da |
| _version_ | 1784821567950159872 |
|---|---|
| author | Oertel, Michael Hering, Dominik Nacke, Nina Kittel, Christopher Kröger, Kai Kriz, Jan Fuchs, Michael Baues, Christian Vordermark, Dirk Engenhart-Cabillic, Rita Herfarth, Klaus Lukas, Peter Schmidberger, Heinz Marnitz, Simone Borchmann, Peter Engert, Andreas Haverkamp, Uwe Eich, Hans Theodor |
| author_facet | Oertel, Michael Hering, Dominik Nacke, Nina Kittel, Christopher Kröger, Kai Kriz, Jan Fuchs, Michael Baues, Christian Vordermark, Dirk Engenhart-Cabillic, Rita Herfarth, Klaus Lukas, Peter Schmidberger, Heinz Marnitz, Simone Borchmann, Peter Engert, Andreas Haverkamp, Uwe Eich, Hans Theodor |
| author_sort | Oertel, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621491 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96214912022-11-01 P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial Oertel, Michael Hering, Dominik Nacke, Nina Kittel, Christopher Kröger, Kai Kriz, Jan Fuchs, Michael Baues, Christian Vordermark, Dirk Engenhart-Cabillic, Rita Herfarth, Klaus Lukas, Peter Schmidberger, Heinz Marnitz, Simone Borchmann, Peter Engert, Andreas Haverkamp, Uwe Eich, Hans Theodor Hemasphere Radiotherapy Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621491/ http://dx.doi.org/10.1097/01.HS9.0000890936.73031.da Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Radiotherapy Oertel, Michael Hering, Dominik Nacke, Nina Kittel, Christopher Kröger, Kai Kriz, Jan Fuchs, Michael Baues, Christian Vordermark, Dirk Engenhart-Cabillic, Rita Herfarth, Klaus Lukas, Peter Schmidberger, Heinz Marnitz, Simone Borchmann, Peter Engert, Andreas Haverkamp, Uwe Eich, Hans Theodor P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial |
| title | P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial |
| title_full | P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial |
| title_fullStr | P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial |
| title_full_unstemmed | P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial |
| title_short | P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial |
| title_sort | p092: estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the ghsg hd 17 trial |
| topic | Radiotherapy |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621491/ http://dx.doi.org/10.1097/01.HS9.0000890936.73031.da |
| work_keys_str_mv | AT oertelmichael p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT heringdominik p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT nackenina p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT kittelchristopher p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT krogerkai p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT krizjan p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT fuchsmichael p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT baueschristian p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT vordermarkdirk p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT engenhartcabillicrita p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT herfarthklaus p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT lukaspeter p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT schmidbergerheinz p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT marnitzsimone p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT borchmannpeter p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT engertandreas p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT haverkampuwe p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial AT eichhanstheodor p092estimatingthedosimetricbenefitofinvolvednoderadiotherapyincomparisontoinvolvedfieldradiotherapyimplicationsfromtheghsghd17trial |